<SEC-DOCUMENT>0001193125-20-050131-index.html : 20200226
<SEC-HEADER>0001193125-20-050131.hdr.sgml : 20200226
<ACCEPTANCE-DATETIME>20200226163533
ACCESSION NUMBER:		0001193125-20-050131
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20200226
DATE AS OF CHANGE:		20200226

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NAVIDEA BIOPHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000810509
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				311080091
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-43603
		FILM NUMBER:		20656298

	BUSINESS ADDRESS:	
		STREET 1:		4995 BRADENTON AVENUE
		STREET 2:		SUITE 240
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147937500

	MAIL ADDRESS:	
		STREET 1:		4995 BRADENTON AVENUE
		STREET 2:		SUITE 240
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEOPROBE CORP
		DATE OF NAME CHANGE:	19940714

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Scott John K Jr.
		CENTRAL INDEX KEY:			0001753763

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	MAIL ADDRESS:	
		STREET 1:		5251 DTC PARKWAY, SUITE 285
		CITY:			GREENWOOD VILLAGE
		STATE:			CO
		ZIP:			80111
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>d846727dsc13da.htm
<DESCRIPTION>SC 13D/A
<TEXT>
Document 1 - file: d846727dsc13da.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A
<SEQUENCE>2
<FILENAME>d846727dex99a.htm
<DESCRIPTION>EX-99.A
<TEXT>
Document 2 - file: d846727dex99a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.B
<SEQUENCE>3
<FILENAME>d846727dex99b.htm
<DESCRIPTION>EX-99.B
<TEXT>
Document 3 - file: d846727dex99b.htm

</DOCUMENT>
</SEC-DOCUMENT>